CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,232 | -25.0% | 1,730 | 0.0% | 0.00% | – |
| Q2 2023 | $2,976 | -0.8% | 1,730 | 0.0% | 0.00% | – |
| Q1 2023 | $3,000 | +99900.0% | 1,730 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 1,730 | -60.7% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 4,402 | +47.9% | 0.00% | – |
| Q2 2022 | $5,000 | -99.4% | 2,977 | -99.0% | 0.00% | – |
| Q1 2022 | $814,000 | -38.8% | 305,032 | -0.7% | 0.00% | – |
| Q4 2021 | $1,330,000 | -18.4% | 307,229 | -4.1% | 0.00% | – |
| Q3 2021 | $1,630,000 | -24.6% | 320,266 | -6.2% | 0.00% | – |
| Q2 2021 | $2,163,000 | +286.9% | 341,535 | +373.0% | 0.00% | – |
| Q1 2021 | $559,000 | +5.9% | 72,206 | -10.3% | 0.00% | – |
| Q4 2020 | $528,000 | -14.6% | 80,524 | -12.8% | 0.00% | – |
| Q3 2020 | $618,000 | -25.4% | 92,305 | -7.3% | 0.00% | – |
| Q2 2020 | $828,000 | -38.7% | 99,580 | -43.4% | 0.00% | – |
| Q1 2020 | $1,350,000 | -56.0% | 176,013 | -52.3% | 0.00% | -100.0% |
| Q4 2019 | $3,067,000 | +209.5% | 369,005 | +174.8% | 0.00% | – |
| Q3 2019 | $991,000 | -26.6% | 134,262 | +5.5% | 0.00% | – |
| Q2 2019 | $1,351,000 | -6.6% | 127,293 | -5.3% | 0.00% | – |
| Q1 2019 | $1,446,000 | -33.1% | 134,459 | -6.0% | 0.00% | – |
| Q4 2018 | $2,161,000 | -22.4% | 143,070 | -5.0% | 0.00% | -100.0% |
| Q3 2018 | $2,786,000 | -12.9% | 150,584 | +7.6% | 0.00% | 0.0% |
| Q2 2018 | $3,199,000 | -44.1% | 139,931 | -30.4% | 0.00% | 0.0% |
| Q1 2018 | $5,720,000 | +11.3% | 201,061 | -17.4% | 0.00% | 0.0% |
| Q4 2017 | $5,141,000 | +19.3% | 243,539 | +2.1% | 0.00% | 0.0% |
| Q3 2017 | $4,310,000 | +14.5% | 238,550 | -1.7% | 0.00% | 0.0% |
| Q2 2017 | $3,763,000 | +17.3% | 242,750 | +30.7% | 0.00% | 0.0% |
| Q1 2017 | $3,208,000 | +924.9% | 185,778 | +551.5% | 0.00% | – |
| Q4 2016 | $313,000 | – | 28,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |